Please ensure Javascript is enabled for purposes of website accessibility

Why Airline Shares Are Soaring Today

By Lou Whiteman – Aug 24, 2020 at 12:49PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

COVID-19 vaccine and treatment news have the stocks flying high on Monday.

What happened

Airline shares took off on Monday on positive developments in the global fight against COVID-19, including a report that President Donald Trump could green-light an experimental vaccine made by AstraZeneca by October. The airlines desperately need to put COVID-19 behind them if they have any hope of really getting airborne, and hopeful medical news caused investors to buy into the stocks.

Shares of United Airlines Holdings (UAL -3.54%) and American Airlines Group (AAL -2.87%) led the sector higher on Monday, each up more than 9% as of 12:45 p.m. EDT. Delta Air Lines (DAL -3.45%), JetBlue Airways (JBLU -4.05%), and Spirit Airlines (SAVE -3.31%) were each up more than 8%, while Southwest Airlines (LUV -2.12%), Alaska Air Group (ALK -4.83%), Hawaiian Holdings (HA -1.65%), and Allegiant Travel (ALGT -5.41%) were all up 5% or more.

So what

Airline stocks have been hit hard by the pandemic, which caused travel demand to crater back in March and April and has kept passengers from flying through the summer. Industry revenue was down more than 80% from last year in the second quarter, and with what little demand there was tied to summer vacations airlines are bracing for further reductions in the months to come.

Airlines are doing what they can to make travelers feel safe, but consumers have said repeatedly they are unlikely to return to the skies in large numbers until there is a widely available COVID-19 vaccine. The stocks were up Monday on talk that the AstraZeneca vaccine could be ahead of schedule, and a Food and Drug Administration decision over the weekend to allow an experimental plasma therapy as treatment for COVID-19 patients.

A plane flying over clouds.

Image source: Getty Images.

Anything that can push the vaccine timetable forward would be bullish for airlines, and new treatments that hopefully make the pandemic less lethal could help encourage demand as well.

United and American are likely flying highest in the sector because among the "big four" carriers they are seen as more vulnerable than Delta and Southwest, with American in particular being watched due to its high debt load. They've also been more aggressive in trying to capture what little demand is out there, and would likely be the big beneficiaries if these headlines do lead to even a modest uptick in demand.

Shares of Southwest, Alaska, and Allegiant, meanwhile, have held up better since the pandemic began and have tended to react more modestly during the recovery as well. Hawaiian, with its niche route network, will likely see its recovery tied to the overall health of the U.S. and Asian economies once the pandemic is over, and could lag its airline rivals if Hawaii or the U.S. limits international visitors for some time after when there is a vaccine.

Now what

Investors should be careful not to get too excited about any headline concerning progress toward a vaccine or treatment for COVID-19. Investors in biotech stocks know there are a lot of moving parts in vaccine and medicine development, and promising developments don't always lead to cures.

Airlines are doing what they can to encourage people to fly, but absent a vaccine, that's a tall order. The going assumption right now is that it will be the second quarter of 2021, at the earliest, before a vaccine is widespread and airlines begin to regain their footing, and it will be at least 2022 before travel demand returns to pre-pandemic levels.

The industry probably has enough capital to survive that long, but any step forward would be a welcome development. It makes sense for investors to cheer good news on the medical front, but given the continued risks and uncertainty it is best to focus on the top stocks in the industry and be careful about getting too excited about any one development.

Lou Whiteman owns shares of Delta Air Lines and Spirit Airlines. The Motley Fool owns shares of Spirit Airlines. The Motley Fool recommends Alaska Air Group, Delta Air Lines, Hawaiian Holdings, JetBlue Airways, and Southwest Airlines. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Alaska Air Group, Inc. Stock Quote
Alaska Air Group, Inc.
ALK
$38.81 (-4.83%) $-1.97
JetBlue Airways Corporation Stock Quote
JetBlue Airways Corporation
JBLU
$6.63 (-4.05%) $0.28
Southwest Airlines Co. Stock Quote
Southwest Airlines Co.
LUV
$31.37 (-2.12%) $0.68
Delta Air Lines, Inc. Stock Quote
Delta Air Lines, Inc.
DAL
$28.02 (-3.45%) $-1.00
Spirit Airlines, Inc. Stock Quote
Spirit Airlines, Inc.
SAVE
$20.77 (-3.31%) $0.71
United Airlines Holdings, Inc. Stock Quote
United Airlines Holdings, Inc.
UAL
$31.90 (-3.54%) $-1.17
Hawaiian Holdings, Inc. Stock Quote
Hawaiian Holdings, Inc.
HA
$13.14 (-1.65%) $0.22
Allegiant Travel Company Stock Quote
Allegiant Travel Company
ALGT
$75.94 (-5.41%) $-4.34
American Airlines Group Inc. Stock Quote
American Airlines Group Inc.
AAL
$11.86 (-2.87%) $0.35

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.